GlassScriptPhysician profile
Jared Lee Harnack
NPI 1093249419
$335.93
in general payments reported to CMS, 2019-2025
13 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.91 · 2022: $44.32 · 2023: $63.06 · 2024: $46.14 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $63.83 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $47.50 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $45.41 | 2024-2025 | Qelbree |
| Alkermes, INC. | $30.56 | 2022-2025 | Vivitrol |
| Indivior INC. | $22.99 | 2025 | Sublocade |
| Vanda Pharmaceuticals INC. | $19.71 | 2025 | Fanapt |
| Axsome Therapeutics, INC. | $17.52 | 2023 | Auvelity |
| Janssen Pharmaceuticals, INC | $16.18 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.88 | 2024 | Uzedy |
| Otsuka America Pharmaceutical, INC. | $15.43 | 2023 | Abilify Maintena, Rexulti |
| Lundbeck LLC | $15.13 | 2023 | Brintellix |
| Takeda Pharmaceuticals U.S.A., INC. | $13.29 | 2021 | |
| Sunovion Pharmaceuticals INC. | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Harnack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.